METHOD FOR SELECTING TREATMENT OF IODINE DEFICIENCY IN PREGNANT WOMEN

摘要

A method for selecting the treatment of iodine deficiency in the pregnant women provides for examining the content of thyroid hormones, the level of iodine excretion with urine. The preparations of potassium iodide and/or Livothyroxine are used throughout gestation term under control of the parameters of thyroid status and iodine excretion (each 6-8 weeks). Free triiodide thyronine (FT3) and free thyroxine (FT4) are measured in the blood of pregnant woman FT3/FT4 ratio is calculated. When iodine excretion with urine is below 100 µg/L and FT3/FT4 0.28, potassium iodide is administered daily at a dose of 100-250 µg/day with concomitant intramuscular injections of Placenta-compositum once in three days in a volume of 2.2 mL when gestation term is 7-8 weeks (7 injections per course of treatment). When iodine excretion with urine is below 100 µg/L and FT3/FT40.28, potassium iodide is administered daily at a dose of 100-200 µg/day with Livothyroxine and Placenta-compositum once in three days in a volume of 2.2 mL when gestation term is 7-8 weeks and 16-18 weeks (7 injections per course of treatment).